Empress

Empress Therapeutics

Founded by Flagship Pioneering in 2020, Empress Therapeutics generates good medicines, fast, by starting with chemistry inside the human body. The Empress Chemilogics™ platform uses novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body to create first- or best-in-class oral medicines for a broad range of diseases quickly, predictably, and cost-effectively.

Content by Empress Therapeutics

An illustration of a blue capsule with particles resembling molecules dispersing from it
| 5 min read
Industry Perspectives
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Bands of diffused color illustrating pigment separation.
Rethinking separation science with supercritical fluids
Discover how supercritical fluids expand chromatographic capabilities across diverse analytical challenges.
Infographics
Shimadzu Corporation Logo
A 3D molecular visualization of antibody-like protein structures with attached yellow payloads floating against a dark, space-like background.
Advancing bioconjugate development through innovative approaches
Evolving approaches to conjugation chemistry and linker–payload design are helping address persistent challenges in bioconjugate development.
Whitepaper
XDC Logo
Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Advancing predictive in vitro models
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
Webinars
lonza logo
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue